Melanotan-2: Community Protocols & Reports
Aggregated community experiences, protocols, and stacking patterns
Community-Sourced Information
The protocols and reports on this page are gathered from online communities and forums. They represent anecdotal experiences, not clinical evidence. Individual results vary significantly. This information is not medical advice and should not replace consultation with a qualified healthcare provider. Always verify dosing and safety information with peer-reviewed research before making any decisions.
For peer-reviewed dosing protocols, see the clinical dosing guide.
Browse community protocols for all 130 peptides โ
๐TL;DR
- โข4 community protocols documented
- โขEvidence level: Structured Community Data
- โขBased on 500 community reports
- โข2 stacking patterns reported
Clinical vs. Community Protocol Differences
How community-reported protocols differ from clinical research protocols.
| Aspect | Clinical Approach | Community Approach | Significance |
|---|---|---|---|
| Dosing Approach | The Phase I clinical study used weight-based dosing of 0.01 mg/kg daily for up to 14 days via subcutaneous injection. This resulted in measurable increases in skin pigmentation. | Community uses fixed doses (0.25-0.5 mg) rather than weight-based dosing, with a loading phase of 2-4 weeks followed by maintenance dosing. Loading doses are generally lower than clinical research doses on a per-kg basis. | moderate Community doses are lower per kg than clinical research, which may reduce side effects while still producing tanning effects when combined with UV exposure. |
| UV Exposure Combination | Research studies measured pigmentation changes with and without UV exposure. MT-2 enhances melanogenesis which can be further amplified by UV exposure. | Community universally combines MT-2 with UV exposure (sun or tanning bed) to accelerate and deepen tanning. Some users report minimal tanning without UV exposure, while others note enhanced pigmentation even without deliberate sun exposure. | moderate The combination with UV exposure amplifies tanning results but also increases UV-related skin risks. The concept that MT-2 provides photoprotection is debated. |
| Off-Target Effects | Clinical research documented non-selective melanocortin receptor activation causing nausea, flushing, fatigue, spontaneous erections (MC4R), and appetite suppression (MC4R). | Community acknowledges and sometimes actively seeks off-target effects, particularly libido enhancement and appetite suppression. Nausea is managed through lower starting doses, anti-nausea medications, and bedtime dosing. | moderate Non-selective melanocortin activation means MT-2 produces multiple effects beyond tanning. Community members should be aware of all melanocortin receptor-mediated effects. |
| Mole Monitoring | Clinical observations and case reports document that MT-2 can darken existing moles and potentially affect atypical nevi. Dermatological monitoring is recommended. | Community members report reversible darkening of moles as a common side effect. Most experienced users recommend photographing moles before starting MT-2 and monitoring for asymmetric changes. Dermatologist consultations are recommended but not always followed. | high Mole darkening and potential effects on atypical nevi are the most significant safety concern with MT-2 community use. |
Compare these community approaches with published research findings.
Community Protocols
Standard Loading Protocol
Popular- Route
- Subcutaneous
- Dose
- 0.25-0.5 mg
- Frequency
- Once daily
- Duration
- 2-4 weeks (loading), then maintenance
Most commonly reported loading protocol; dose based on body weight; combined with UV exposure
Low-Dose Conservative Protocol
Popular- Route
- Subcutaneous
- Dose
- 0.1-0.25 mg
- Frequency
- Once daily
- Duration
- 3-4 weeks (loading), then biweekly maintenance
Lower dose to minimize side effects (nausea, flushing); preferred by first-time users
Weight-Based Research Protocol
Common- Route
- Subcutaneous
- Dose
- 0.01 mg/kg body weight
- Frequency
- Once daily
- Duration
- Up to 2 weeks
Derived from clinical research dosing; approximately 0.7-0.8 mg/day for a 175 lb individual
Maintenance Protocol
Popular- Route
- Subcutaneous
- Dose
- 0.25-0.5 mg
- Frequency
- Once or twice weekly
- Duration
- Ongoing (during sun season)
After achieving desired tan; reduced frequency to maintain pigmentation
Stacking Patterns
Tanning + Libido Stack
CommonMT-2 for tanning with PT-141 for targeted libido enhancement when more precise sexual function support is desired beyond MT-2's non-selective MC4R activation
Tanning + Fat Loss Stack
NicheSome community members note MT-2's appetite-suppressing MC4R effects as a bonus alongside tanning; not typically stacked with dedicated fat loss peptides due to overlapping melanocortin activity
Check stack compatibility and review potential side effects before combining peptides.
Unlock community dosing protocols and stacking combos
See the exact doses, routes, and schedules 500+ self-experimenters report. Free with email.
150+ peptide profiles ยท 30+ comparisons ยท 18 research tools
Sources
- Reddit r/Peptides|Melanotan-2 tanning protocol discussions and experience reports(accessed 2026-02-16)
- More Plates More Dates|Melanotan II Results (With Before And After Pictures)(accessed 2026-02-16)
- Karger Dermatology|Melanotan II User Experience: A Qualitative Study of Online Discussion Forums(accessed 2026-02-16)
- Peptides.org|Melanotan 2 Dosage Calculator and Chart(accessed 2026-02-16)
- DermNet NZ|Melanotan II overview and safety information(accessed 2026-02-16)
- Adam Niall|Comprehensive Guide to Melanotan 2: Benefits, Risks, and Dosing(accessed 2026-02-16)
- British Journal of Dermatology|User experiences of Melanotan II injection for tanning (2024 study)(accessed 2026-02-16)
Community Evidence Overview#
This page presents aggregated community protocols and anecdotal reports for Melanotan-2 (MT-2). The information below is gathered from peptide forums, tanning communities, Reddit, and published qualitative research on MT-2 users. This is not clinical evidence and should not be used as medical guidance.
Melanotan-2 has one of the largest and most established community user bases of any research peptide. A 2021 qualitative study published in Dermatology (Gilhooley et al.) analyzed 623 discussion entries from 205 participants across online forums, finding that users primarily sought MT-2 for tanning purposes, often before vacations or fitness competitions. The study highlighted risks including misinformation, infectious disease transmission from shared injection equipment, and contamination hazards from unregulated products.
Understanding Protocol Divergence#
Community-Derived Loading/Maintenance Structure#
The loading and maintenance protocol structure is entirely community-derived. Clinical research used fixed-duration dosing periods, while the community has developed a phased approach: higher-frequency loading to build pigmentation, followed by lower-frequency maintenance to sustain it. This pragmatic approach reflects thousands of users refining their protocols over years.
UV Exposure Integration#
Community protocols universally incorporate UV exposure (sun or tanning bed) as an essential component. While research shows MT-2 can increase pigmentation without UV, the community consensus is that UV exposure dramatically enhances results. This creates a complex risk calculus, as the UV exposure itself carries skin cancer risks.
Mole Monitoring#
Darkening of existing moles is one of the most consistently reported effects. The community has developed self-monitoring practices (photographing moles before starting, watching for asymmetric changes) but dermatological oversight is recommended. The reversibility of mole darkening after discontinuation is generally reported but not guaranteed.
Commonly Reported Outcomes#
- Skin darkening: Universal among users, with degree depending on baseline skin type, dose, and UV exposure
- Nausea: The most common side effect during loading, managed through dose reduction and timing
- Increased libido: Reported by most users due to non-selective MC4R activation
- Appetite suppression: Commonly noted as a secondary effect
- Mole darkening: Reversible in most cases after discontinuation
- Freckling: New freckles or darkening of existing freckles reported by fair-skinned users
Important Caveats#
- MT-2 is not FDA-approved and regulatory agencies have issued warnings
- Long-term effects on melanocyte transformation and melanoma risk are unknown
- UV exposure combined with MT-2 creates additional skin cancer risk
- Mole changes require dermatological monitoring
- Product quality and purity vary significantly between sources
Related Reading#
Subscribe to see vendor options
Free access to verified vendor scores, pricing, and suppliers.
150+ peptide profiles ยท 30+ comparisons ยท 18 research tools
Frequently Asked Questions About Melanotan-2
Explore Further
Medical Disclaimer
This website is for educational and informational purposes only. The information provided is not intended to diagnose, treat, cure, or prevent any disease. Always consult with a qualified healthcare professional before using any peptide or supplement.